(WNDU) - Prostate cancer is one of the most common types of cancer in men, as almost 35,000 will die from it this year. It develops when abnormal cells form and grow in the prostate gland. Now, there ...
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality ...
AngioDynamics, Inc. ANGO recently announced that Irreversible Electroporation (IRE) has received Current Procedural Terminology (CPT) Category I codes for the treatment of lesions in the prostate and ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
A unique surgical technique, commonly called NanoKnife, uses electricity to zap hard-to-reach prostate-cancer tumors and promises fewer side effects. Prostate cancer is the most common cancer for men, ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
AVENTURA, Fla. — Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the second most common cancer in men. Brewton, 66, who is among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results